Implant Sciences Cp (IMSC) 0.7535 $IMSC
Implant Sciences Continues to Expand its Growing EU Market Share with QS-B220s Sold to Austrian Airports
PR Newswire - Tue Aug 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.
Implant Sciences Adds Romanian Airports to its list of Customers, Achieves Sales to a Total of 70 Countries Worldwide
PR Newswire - Tue Aug 11, 10:20AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences' trace detectors have been sold to customers in 70 different countries around the world, amounting to a total of approximately 4,400 units.
Implant Sciences Wins 50 Unit German Airport Order; Market Recognition of Superior Technology Fuels European Market Expansion
PR Newswire - Thu Jul 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.
Implant Sciences Expands its Non-Contact Sampling Innovation with Award of its 19th Patent
PR Newswire - Wed Jul 29, 9:27AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the award of its 19th patent. Titled "Trace Chemical Particle Release Nozzle" (Patent No. 9,067,219), this patent enhances Implant Sciences' non-contact sampling capability to allow for its integration and use in a wide range of high through-put screening deployment scenarios.
Implant Sciences Achieves First Major Sale into Drug Detection Market
PR Newswire - Wed Jul 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that, in a landmark sale for the company, it has sold 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico. The units, which are replacing competing systems, will be deployed for drug detection.
Implant Sciences Wins Parisian Airport Tender for 178 ETDs
PR Newswire - Tue Jul 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports.
45 Implant Sciences Explosives Trace Detectors Sold to Czech Republic International Airports
PR Newswire - Mon Jul 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 45 QS-B220 desktop explosives trace detectors across international airports in the Czech Republic.
Implant Sciences Announces Shipment of Additional $1.2 Million in Trace Detection Systems to Customers Globally
PR Newswire - Wed Jul 15, 9:22AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of both its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
Four Major Airports in Poland Join Other European Airports in Selecting Implant Sciences' QS-B220 Trace Detectors to Meet European Security Regulations
PR Newswire - Thu Jun 04, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 16 of its QS-B220 desktop explosives trace detectors to four major international airports in Poland.
Implant Sciences Signs Deal for Up to $5 million with Ryan Security Technologies Ltd. to Expand Sales in China
PR Newswire - Mon Jun 01, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed an exclusive distribution agreement, worth up to $5 million, with Ryan Security Technologies Ltd. to manage sales and service of its products throughout all of China.
Another Major International European Airport Selects Implant Sciences' QS-B220
PR Newswire - Tue May 19, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 20 of its QS-B220 desktop explosives trace detectors into Belgium for aviation security. Shipment of these units is already underway and is expected to be completed, per customer request, over the next several months.
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
Implant Sciences Continues to Expand its Growing EU Market Share with QS-B220s Sold to Austrian Airports
PR Newswire - Tue Aug 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.
Implant Sciences Adds Romanian Airports to its list of Customers, Achieves Sales to a Total of 70 Countries Worldwide
PR Newswire - Tue Aug 11, 10:20AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences' trace detectors have been sold to customers in 70 different countries around the world, amounting to a total of approximately 4,400 units.
Implant Sciences Wins 50 Unit German Airport Order; Market Recognition of Superior Technology Fuels European Market Expansion
PR Newswire - Thu Jul 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.
Implant Sciences Expands its Non-Contact Sampling Innovation with Award of its 19th Patent
PR Newswire - Wed Jul 29, 9:27AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the award of its 19th patent. Titled "Trace Chemical Particle Release Nozzle" (Patent No. 9,067,219), this patent enhances Implant Sciences' non-contact sampling capability to allow for its integration and use in a wide range of high through-put screening deployment scenarios.
Implant Sciences Achieves First Major Sale into Drug Detection Market
PR Newswire - Wed Jul 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that, in a landmark sale for the company, it has sold 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico. The units, which are replacing competing systems, will be deployed for drug detection.
Implant Sciences Wins Parisian Airport Tender for 178 ETDs
PR Newswire - Tue Jul 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports.
45 Implant Sciences Explosives Trace Detectors Sold to Czech Republic International Airports
PR Newswire - Mon Jul 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 45 QS-B220 desktop explosives trace detectors across international airports in the Czech Republic.
Implant Sciences Announces Shipment of Additional $1.2 Million in Trace Detection Systems to Customers Globally
PR Newswire - Wed Jul 15, 9:22AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of both its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
Four Major Airports in Poland Join Other European Airports in Selecting Implant Sciences' QS-B220 Trace Detectors to Meet European Security Regulations
PR Newswire - Thu Jun 04, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 16 of its QS-B220 desktop explosives trace detectors to four major international airports in Poland.
Implant Sciences Signs Deal for Up to $5 million with Ryan Security Technologies Ltd. to Expand Sales in China
PR Newswire - Mon Jun 01, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed an exclusive distribution agreement, worth up to $5 million, with Ryan Security Technologies Ltd. to manage sales and service of its products throughout all of China.
Another Major International European Airport Selects Implant Sciences' QS-B220
PR Newswire - Tue May 19, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 20 of its QS-B220 desktop explosives trace detectors into Belgium for aviation security. Shipment of these units is already underway and is expected to be completed, per customer request, over the next several months.
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
